Template:Did you know nominations/Javed Agrewala

The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.

The result was: promoted by Cwmhiraeth (talk) 06:04, 17 April 2017 (UTC)

Javed Agrewala

(

• Back to T:TDYK
• Article history

)

• ... that Javed Agrewala and his team developed a vaccination program against Mycobacterium tuberculosis for which he holds a US patent? Source: SS Bhatnagar Prize citation, Patent details
  • ALT1:... that Javed Agrewala patented his findings on the immunosuppressive activity of Caerulomycin A which was later sold to Nostrum Pharmaceuticals for US$ 3 million? Source: Indian National Science Academy

• Reviewed: Template:Did you know nominations/Somnath Sharma
• Comment: For accessing INSA site, please click A and select JN Agrewala to see details

Created by Tachs (talk). Self-nominated at 12:04, 30 March 2017 (UTC).

General: Article is new enough and long enough
New enough: Long enough:

Policy: Article is sourced, neutral, and free of copyright problems
Adequate sourcing: Neutral: Free of copyright violations, plagiarism, and close paraphrasing:

Hook: Hook has been verified by provided inline citation
Cited: Interesting:

QPQ: Done.

Overall: Article was created on 29 March, same day nominated for DKY. Article has 6,282 characters of readable prose. Use of Earwig's Copyvio Detector did not detect copyright violations. I am a novice DYK reviewer, so a second opinion is probably called for. Shortsword (talk) 00:07, 15 April 2017 (UTC)